Skip to main content

Table 2 The raw data showing the frequency of NK, CTL and Treg cells in each group (n = 3)

From: Activation of cellular immunity and marked inhibition of liver cancer in a mouse model following gene therapy and tumor expression of GM-SCF, IL-21, and Rae-1

Group

CD11b + CD27 + (%)

CD3 + CD8 + (%)

CD4 + CD25 + Foxp3 + (%)

NK

CTL

Treg cells

IRES/combination group

16.24

15.60 ± 0.66

34.58

33.60 ± 1.00

0.41

0.37 ± 0.04

15.62

33.64

0.37

14.95

32.59

0.33

IRES/GM-CSF-IL21 group

13.78

13.40 ± 0.33

27.93

26.59 ± 1.33

1.01

0.87 ± 0.14

13.24

26.58

0.86

13.18

25.27

0.73

IRES/IL21 group

10.32

10.03 ± 0.26

24.78

24.36 ± 0.41

1.34

1.26 ± 0.07

9.93

24.32

1.26

9.83

23.97

1.19

IRES/GM-CSF group

9.97

9.80 ± 0.15

24.79

24.07 ± 0.82

1.32

1.21 ± 0.12

9.74

24.24

1.23

9.69

23.18

1.09

IRES/GFP group

6.72

6.60 ± 0.11

21.97

21.61 ± 0.36

2.01

1.95 ± 0.08

6.58

21.59

1.98

6.51

21.26

1.86

Control group

6.45

6.36 ± 0.10

21.73

21.46 ± 0.24

2.20

2.08 ± 0.11

6.25

21.37

2.05

6.37

21.28

1.98